Growth Metrics

Neuphoria Therapeutics (NEUP) Profit After Tax Growth (1y) (2024 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 65.80%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.05%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -290.15%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 59.59%
7 Evaxion A 62.56 Bn 62.54 Bn - -129.68%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.08%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,228.66%
10 Neuphoria Therapeutics 28.35 Mn 8.95 Mn - -104.44%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -104.44%
Dec 31, 2025 198.11%
Sep 30, 2025 -1,130.95%
Jun 30, 2025 -230.26%
Mar 31, 2025 506.75%
Dec 31, 2024 58.28%
Sep 30, 2024 85.29%